Search results for "delivery"

showing 10 items of 1271 documents

Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue

2016

Levodopa (l-DOPA) is the most effective pharmacologic agent in Parkinson's disease and remains the "gold standard". Nevertheless, in long-term treatments, dyskinesias and motor complications can emerge. In this work, the combined use of l-DOPA methylester hydrochloride prodrug (LDME) with transbuccal drug delivery was supposed as a good alternative method to optimize the bioavailability of l-DOPA, to maintain constant plasma levels and to decrease the drug unwanted effects. The effects of environmental pH on buccal delivery of LDME were evaluated ex vivo. The increase of pH value from 5.8 to 6.2 implies an improvement of drug permeation. Since the pH increase causes the raising of hydrolyti…

DrugHydrochloridemedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyPharmacologyAntiparkinson AgentsLevodopachemical stability03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineDrug StabilitySettore MED/28 - Malattie OdontostomatologicheProdrugsmedia_commonBuccal permeationMouthintellidrug deviceMouth MucosaParkinson DiseaseGeneral MedicineBuccal administrationPermeationProdrug021001 nanoscience & nanotechnologytransmucosal drug deliveryBioavailabilitychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryprodrug0210 nano-technology030217 neurology & neurosurgeryEx vivo
researchProduct

Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat

2020

Sufficient colonic absorption is necessary for all systemically acting drugs in dosage forms that release the drug in the large intestine. Preclinically, colonic absorption is often investigated using the rat single-pass intestinal perfusion model. This model can determine intestinal permeability based on luminal drug disappearance, as well as the effect of permeation enhancers on drug permeability. However, it is uncertain how accurate the rat single-pass intestinal perfusion model predicts regional intestinal permeability and absorption in human. There is also a shortage of systematic in vivo investigations of the direct effect of permeation enhancers in the small and large intestine. In …

DrugKetoprofenmedia_common.quotation_subjectlcsh:RS1-441Pharmaceutical ScienceGastroenterology and Hepatology02 engineering and technologyPharmacology030226 pharmacology & pharmacyArticleDosage formlcsh:Pharmacy and materia medicaJejunumPharmaceutical Sciences03 medical and health sciences0302 clinical medicineabsorption-modifying excipientsintestinal perfusionIn vivoGastroenterologimedicineLarge intestineregional intestinal permeabilitymedia_commonIntestinal permeabilityChemistrypermeation enhancersPermeationFarmaceutiska vetenskaper021001 nanoscience & nanotechnologymedicine.diseasepharmaceutical developmentmedicine.anatomical_structureoral peptide delivery0210 nano-technologymedicine.drugPharmaceutics
researchProduct

PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.

2018

The oral controlled release (CR) formulations have become more important in recent years. Among them, the polymeric nanoparticles have been thoroughly studied during the last decades, consequently they are extensively employed for a broad range of applications and drugs. The objective of this research was to develop polymeric nanoparticles (NPs) of ibuprofen with poly(lactic-co-glycolic) acid (PLGA) as polymer, and to test their applicability for oral CR formulations development. Different proportions of drug/polymer were employed to develop the ibuprofen NPs and their in vitro release profiles were analysed. The in situ segmental permeability of ibuprofen was tested in Wistar rat and demon…

DrugMaleColonPolymersmedia_common.quotation_subjectPharmaceutical ScienceIbuprofen02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivomedicineAnimalsLactic AcidRats Wistarmedia_commonchemistry.chemical_classificationDrug CarriersChromatographyorganic chemicalstechnology industry and agriculturePolymer021001 nanoscience & nanotechnologyIbuprofenControlled releaseRatsPLGAchemistryIntestinal AbsorptionPermeability (electromagnetism)Delayed-Action PreparationsNanoparticles0210 nano-technologyPolyglycolic Acidmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.

2007

An increasing number of newly developed drugs show bioavailability problems due to poor water solubility. Formulating the drugs as nanosuspensions may help to overcome these problems by increasing saturation solubility and dissolution velocity. In the present study the bioavailability of the poorly soluble fenofibrate following oral administration was investigated in rats. Four formulations were tested: a nanosuspension type DissoCube(R), one solid lipid nanoparticle (SLN) preparation and two suspensions of micronized fenofibrate as reference formulations, one suspension in sirupus simplex and a second in a solution of hydroxyethy-cellulose in physiological saline. Both colloidal drug deliv…

DrugMalemedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyModels BiologicalDosage formPharmacokineticsFenofibrateSuspensionsSolid lipid nanoparticlemedicineAnimalsComputer SimulationTissue DistributionSolubilityRats Wistarmedia_commonHypolipidemic AgentsFenofibrateChemistryLipidsBioavailabilityRatsSolubilityDrug deliveryNanoparticlesmedicine.drugAdvanced drug delivery reviews
researchProduct

Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system

2017

A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin…

DrugMaterials scienceAtomic and Molecular Physics and Opticmedia_common.quotation_subjectHyaluronic acidCD44 receptorBioengineering02 engineering and technologyPharmacology010402 general chemistry01 natural sciencesCD44 receptor; Doxorubicin; Hyaluronic acid; Nanomedicine; Polybenzofulvene; Tri-component polymer brush TCPB; Bioengineering; Chemistry (all); Atomic and Molecular Physics and Optics; Modeling and Simulation; Materials Science (all); Condensed Matter Physicschemistry.chemical_compoundAtomic and Molecular PhysicsHyaluronic acidTri-component polymer brush TCPBmedicineGeneral Materials ScienceDoxorubicinmedia_commonbiologyCD44Chemistry (all)General Chemistry021001 nanoscience & nanotechnologyCondensed Matter PhysicsAtomic and Molecular Physics and Optics0104 chemical sciencesNanomedicinechemistryTargeted drug deliveryDoxorubicinModeling and SimulationDrug deliveryCancer cellbiology.proteinBiophysicsNanomedicineMaterials Science (all)Polybenzofulveneand Optics0210 nano-technologymedicine.drug
researchProduct

In VitroRelease of Local Anaesthetic and Anti-Inflammatory Drugs from Crosslinked Collagen Based Device

2012

The drug delivery systems that are the object of this article take the form of a hydrophilic matrix (collagen or crosslinked collagen) containing a drug. These devices can be used as The model active agents, were chosen from the range of local anaesthetics (lidocaine hydrochloride), anti-inflammatory (diclofenac sodium salt) and antioxydant (caffeic acid). Whatever the drug affinity for water, in the first time of the experiments, the release appears to be systematically delayed when the matrix is crosslinked. For lidocaine hydrochloride based systems, as the amount of drug increases in the matrix, the high gap concentration between the matrix and the buffer solution promote the diffusion a…

DrugMaterials scienceChromatographyPolymers and Plasticsmedia_common.quotation_subjectfood and beveragesGeneral ChemistryDiclofenac SodiumLidocaine HydrochlorideBuffer solutionControlled releaseMatrix (chemical analysis)chemistry.chemical_compoundchemistryDrug deliveryMaterials ChemistryCeramics and CompositesOrganic chemistrySolubilitymedia_commonJournal of Macromolecular Science, Part A
researchProduct

Dense drug-eluting biodegradable Fe-Ag nanocomposites

2021

Abstract Biodegradable metals in orthopedics are aimed to eliminate secondary the surgical intervention for implant removal, and thus improve patient compliance, reduce surgery costs and the risk of infections. In addition, biodegradable implants could be loaded with different drugs to prevent the growth of pathogens and the development of bone infections, kill remaining cancer cells after tumor resection or stimulate bone regeneration. However, drugs undergo thermal decomposition under the conditions of conventional metal fabrication processes. In this work, we describe the fabrication of a dense drug-eluting biodegradable Fe-Ag nanocomposite containing 10 vol% of Ag and loaded with the an…

DrugMaterials scienceLocal drug deliverymedia_common.quotation_subjectCold sinteringTumor resection02 engineering and technology010402 general chemistry01 natural sciencesImplant removalBone biomaterialsDrug-eluting metalsmedicineGeneral Materials ScienceBone regenerationPatient complianceMaterials of engineering and construction. Mechanics of materialsmedia_commonNanocompositeMechanical EngineeringBiodegradable implants021001 nanoscience & nanotechnology0104 chemical sciencesFe-Ag nanocompositesMechanics of MaterialsTA401-492VancomycinBiodegradable metals0210 nano-technologyBiomedical engineeringmedicine.drugMaterials & Design
researchProduct

Polybenzofulvene derivatives bearing dynamic binding sites as potential anticancer drug delivery systems.

2020

In order to obtain new advanced functional materials capable of recognizing drug molecules, the polybenzofulvene backbone of molecular brush poly-6-MOEG-9-TM-BF3k has been functionalized with a “synthetic dynamic receptor” composed of two 1-adamantylurea moieties linked together by means of a dipropyleneamino bridge as in Meijer's bis(adamantylurea) pincer (BAUP). This functional material, bearing synthetic receptors potentially capable of recognizing/loading and then delivering drug molecules, was used to prepare colloidal drug delivery systems (by means of soft interaction with BAUP) for delivering the model anti-cancer drug doxorubicin (DOXO). The resulting nanostructured drug delivery s…

DrugMaterials scienceStereochemistrymedia_common.quotation_subjectBiomedical EngineeringGeneral ChemistryGeneral MedicinePolybenzofulvene drug delivery systems DoxorubicinIn vitroCancer cellDrug deliveryZeta potentialmedicineFluorescence microscopeBiophysicsGeneral Materials ScienceDoxorubicinCytotoxicitymedicine.drugmedia_commonJournal of materials chemistry. B
researchProduct

Antibacterial drug release from a biphasic gel system: Mathematical modelling

2019

Bacterial infections represent an important drawback in the orthopaedic field, as they can develop either immediately after surgery procedures or after some years. Specifically, in case of implants, they are alleged to be troublesome as their elimination often compels a surgical removal of the infected implant. A possible solution strategy could involve a local coating of the implant by an antibacterial system, which requires to be easily applicable, biocompatible and able to provide the desired release kinetics for the selected antibacterial drug. Thus, this work focusses on a biphasic system made up by a thermo-reversible gel matrix (Poloxamer 407/water system) hosting a dispersed phase (…

DrugMaterials sciencemedia_common.quotation_subjectVancomycin HydrochloridePharmaceutical SciencePoloxamer02 engineering and technologyantibacterial drugengineering.material030226 pharmacology & pharmacyDiffusion03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMicro-particleCoatingVancomycinAntibacterial drugmedicineAntibacterial drugmedia_commonGelMathematical modellingReproducibility of ResultsMicro-particlesModels Theoretical021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationKineticsPLGAchemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoantibacterial drug; Gels; Mathematical modelling; Micro-particles; Orthopaedic implantsPoloxamer 407engineeringOrthopaedic implantsDelivery systemImplant0210 nano-technologyGelsmedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies

2009

The prospect of improved cancer therapy using Solid Lipid Nanoparticles (SLNs) as drug delivery system is promising. Sev- eral obstacles frequently encountered with anticancer compounds, such as poor drug solubility, are overcome by delivering them using SLN. Moreover, the intravenous administration of drugs into SLNs can potentially enhance drug blood circulation time and improve drug per- formance by inducing accumulation into tumours by enhanced permeability and retention (EPR) effect. This paper deals with the devel- opment of SLN containing nimesulide, a non-steroidal anti-inflammatory drug with antitumour effect and low solubility in water. Here, SLNs carrying nimesulide were prepared…

DrugMaterials sciencemedia_common.quotation_subjectsolid lipid nanoparticles nimesulide drug deliveryBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringPharmacologyIn vitroSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSolid lipid nanoparticleDrug deliveryZeta potentialmedicineSolubilityCytotoxicityBiotechnologymedia_commonNimesulidemedicine.drugCurrent Nanoscience
researchProduct